View
7
Download
0
Category
Preview:
Citation preview
TNI medical AG - Your partner in respiratory support
TNI® 20 oxy
TNI 20
TNI 20 oxy
TNI 20s oxy
Embla PSG
Embla PG
M+S 310 PG
RESMED C/APAP
BREAS C/APAP
BREAS BiLevel
TNI therapy with nasal insufflationVentilation system for home care treatment of respiratory insufficiency, such as COPD
with O2 connection
Increased quality of life due to our new high-flow respiratory support system.
The TNI®20 oxy provides 5 to 20 liters/minute of a warm, humidified air-oxygen mixture through an applicator into the patient‘s nose. During treatment the nose is not blocked, thus guarante-eing easy breathing.
Therapy success is achieved in patients with COPD II to IV, Cystic Fibrosis and many others.
TNI therapy is a possible addition to LTOT and a new optional alternative to mask ventilation.
Mask pressure sores, leakages and phobia as well as drying out of nasal mucosa are excluded during therapy application.
TNI therapy is free from any side effects.
TNI medical AG Hofmannstrasse 8D 97084 WuerzburgGermany Phone: +49 931 20 79 29 02Fax: +49 931 20 79 29 01info@tni-medical.dewww.tni-medical.de
Freer breathing without mask with an air-oxygen mixture
without mask with O2
Advantages at a glance:
• Opensystemwithapplicator - without mask - leading to increased comfort, no pressure sores in the face, extremely easy application and removal
• Perfecttightness,noleakages;prevention of ophthalmitis or loud noises varying with brea-thing
• Allowsanybodypositionduringsleep, even prone position
• Integratedairhumidificationandwarming;nodryingoutofnoseand mouth
• Easyoperationandcleaningofthe device
• Suitableforclinicalapplicationsand home care treatment
• Addsupto8L/minofoxygen
Please ask for a complete pro-duct catalogue including all study references.
Mode of action:
• Swirlstheair-O2 mixture in the dead space volume.
• Increasesventilationand induces CO2 washout.
• Improvesbreathingefficiency:(VD/VT) and thus alveolar venti-lation (VA).
• Adds„usable“ air-O2 mixture to the VD.
• ReducesthearterialCO2 content by improving VA. (Not achievable by only admini-stering pure oxygen)
• Warmsandhumidifiesthead-ded oxygen.
• Easierexpectorationduetohumidified and warm air.
©2010TNImedicalAG•Itemno.30200046•Version1.1•Subjecttotechnicalalterations
TNI Therapy - Ranges of application TNI®20 TNI®20 oxy TNI®20s oxyAdults: Mild to moderate OSA UARS Overlap Syndrome COPD Stage I COPD Stage II COPDStagesIIandIIIwithpartialinsufficiency COPDStagesIIIandIVwithglobalinsufficiency Fibrosis Followingpartiallungresectionandtransplantation Children and juveniles (extr. high effectiveness and therapy acceptance): Inpatientswithobstructedflow OSA and OSA symptomes Facialabnormalitieswithspec.anatomicfeatures Down‘s syndrome Prematures and infants: Pulmonary dysplasia with need for oxygen Chronicrespiratoryinsufficiency
AlternativeifCPAPtherapycannotbeappliedathome Homecareapplications
TNI Therapy - General informationSettings: Totalflow(L/min) 5to20 5to20 5to25 O2(L/min) 0to8 0to16 DisplayActualFlow Technical data: Medicalproductclass(93/42/EWG) Acousticemission <32dB(A) <32dB(A) Operatingvoltage 100-240VAC 100-240VAC 100-240VAC 50-60Hz 50-60Hz 50-60HzVentilation unit (compressor unit): DimensionsL/W/H(cm) 25/21/23.5 26/21/23.5 Weight(kg) <8.5 <8.5Humidifier unit: DimensionsL/W/H(cm) 26/22/10 26/22/10 26/22/10 Weight(withoutwater)(kg) <2.0 <2.5 <3.0Applicator: TNIApplicatorforadults(Standard) TNIApplicatorforadults(Comfort) TNIPediatricApplicator TNIPediatricAdapter TNIPaedAdapter(BC2745,BC2755) Tubelength(m) 1.8 1.8 1.8
Caption: yes limited no
Recommended